
Governor Gavin Newsom granted California’s 47,000 pharmacists the ability to order and administer coronavirus disease 2019 (COVID-19) tests throughout the state.


Governor Gavin Newsom granted California’s 47,000 pharmacists the ability to order and administer coronavirus disease 2019 (COVID-19) tests throughout the state.

More than one-third of Americans report that COVID-19 has had a serious impact on their mental health.

PPE and appropriate infection control training are vital to keep health care workers safe, according to the researchers from Oregon Health and Science University.

Over the past 5 years, pharmacy residency positions have increased by 46% nationwide.

According to a study, men have higher concentrations of ACE2 in their blood than women, which may be a potential explanation for why men are more susceptible to COVID-19.

Leronlimab has been granted 2 other Fast Track designations as a combination therapy with HAART for HIV and as a treatment for metastatic triple-negative breast cancer.

The study was launched in response to an earlier joint statement issued by the AHA, the ACC, and the Heart Failure Society of America, which urged more research on the subject.

Independent community pharmacy owners in New York City discuss what it’s like to operate a pharmacy and support patients in one of the largest coronavirus disease 2019 (COVID-19) hot spots in the country.

Patients with the coronavirus disease 2019 (COVID-19) are filling more than half of the ICU beds in 40% of the hospitals represented in the survey.

The new order took effect immediately, on May 7, according to the Connecticut Pharmacists Association.

According to a new study, even the sickest patients with COVID-19 who require ventilators in ICUs improve when given treatment that follows existing guidelines for respiratory failure.

Top news of the week from Pharmacy Times® surrounding the novel coronavirus.

FDA recently released new temporary guidelines on non-standard PPE practices for sterile compounding by pharmacy compounders during the COVID-19 pandemic.

Clinicians are becoming increasingly concerned about evidence that COVID-19 could also be a thromboembolic disease.

This discovery is an initial step toward developing a fully human antibody to treat or prevent the coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, according to the study authors.

The Israel Institute for Biological Research presented the country’s Defense Minister Naftali Bennet with a “significant breakthrough” in the search for an antidote to COVID-19 on Monday night.

The National Institutes of Health (NIH) has issued a timely statement emphasizing the importance of asthma awareness and standing with parents, families, advocates, researchers, and health care professionals.

A study to help determine the incidence rate of the coronavirus disease 2019 (COVID-19) in children and their family members has begun enrolling participants in the United States, according to the National Institutes of Health (NIH).

A rapid increase in telemedicine during the coronavirus disease 2019 pandemic could transform the way care is provided in the United States going forward.

Baker and her co-authors used federal employment data to find that 10% of US workers are employed in occupations in which exposure to disease or infection happens at least weekly based on employee and employer self-reports.

The findings of a recent survey from ValuePenguin found that 55% of the 1200 respondents said their mental health is suffering because of COVID-19, more specifically in millennials (63%) and parents with younger children (64%).

The APhA’s program “Addressing the COVID-19 Crisis: An Open Forum Webinar Series for Pharmacists” addressed the new conditions, including that hand sanitizer is compounded according to the following formula consistent with World Health Organization recommendations.

Remdesivir is not approved by the FDA. However, EUA allows for distribution and emergency use for treatment of COVID-19.

A new collaboration agreement was made between Moderna, Inc, and Lonza Ltd, to manufacture Moderna’s mRNA vaccine against the coronavirus disease 2019.

If the majority of Americans were diagnosed with COVID-19, the total cost of hospitalizations, ventilators, and other resources could cost $654 billion.